SCHEMBL8893702

SCHEMBL8893702

N=CC1CCCc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.49
HTR6 P50406 1/20 0.46
ADRA2A P08913 2/20 0.41
ADRA1A P35348 2/20 0.41
CYP2D6 P10635 2/20 0.41
LMNA P02545 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1B P35368 1/20 0.41
HTR1A P08908 1/20 0.41
OPRM1 P35372 1/20 0.41
HTT P42858 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
CHRNA7 P36544 1/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6723016 0.81 IDO1 (0.49) IDO1ADRA2AADRA1ACYP2D6LMNA
SCHEMBL1567118 0.81 IDO1 (0.49) IDO1ADRA2AADRA1ACYP2D6LMNA
SCHEMBL9159890 0.81 IDO1 (0.49) IDO1CYP2D6LMNAHTTALDH1A1
SCHEMBL8699708 0.81 IDO1 (0.49) IDO1CYP2D6LMNAHTTALDH1A1
SCHEMBL29663637 0.81 IDO1 (0.49) IDO1CYP2D6LMNAHTTALDH1A1
SCHEMBL782544 0.81 IDO1 (0.49) IDO1CYP2D6LMNAHTTALDH1A1
SCHEMBL10648765 0.80 IDO1 (0.45) IDO1ADRA2AADRA1ACYP2D6LMNA
SCHEMBL7576444 0.79 SMN1; SMN2 (0.51) IDO1HTTMEN1KMT2ASMN1; SMN2
SCHEMBL7576452 0.79 SMN1; SMN2 (0.51) IDO1HTTMEN1KMT2ASMN1; SMN2
SCHEMBL361005 0.78 IDO1 (0.46) IDO1ADRA2AADRA1ACYP2D6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593967-A Cholecystokinin antagonists, their preparation and therapeutic use WARNER-LAMBERT COMPANY (US) 1997-01-14 US disclosed